Interaction of silicon-based quantum dots with gibel carp liver: oxidative and structural modifications by Loredana Stanca et al.
Stanca et al. Nanoscale Research Letters 2013, 8:254
http://www.nanoscalereslett.com/content/8/1/254NANO EXPRESS Open AccessInteraction of silicon-based quantum dots with
gibel carp liver: oxidative and structural
modifications
Loredana Stanca1, Sorina Nicoleta Petrache1, Andreea Iren Serban1,2, Andrea Cristina Staicu1, Cornelia Sima3,
Maria Cristina Munteanu1, Otilia Zărnescu1, Diana Dinu1* and Anca Dinischiotu1Abstract
Quantum dots (QDs) interaction with living organisms is of central interest due to their various biological and
medical applications. One of the most important mechanisms proposed for various silicon nanoparticle-mediated
toxicity is oxidative stress. We investigated the basic processes of cellular damage by oxidative stress and tissue
injury following QD accumulation in the gibel carp liver after intraperitoneal injection of a single dose of 2 mg/kg
body weight Si/SiO2 QDs after 1, 3, and 7 days from their administration.
QDs gradual accumulation was highlighted by fluorescence microscopy, and subsequent histological changes in
the hepatic tissue were noted. After 1 and 3 days, QD-treated fish showed an increased number of macrophage
clusters and fibrosis, while hepatocyte basophilia and isolated hepatolytic microlesions were observed only after
substantial QDs accumulation in the liver parenchyma, at 7 days after IP injection.
Induction of oxidative stress in fish liver was revealed by the formation of malondialdehyde and advanced oxidation
protein products, as well as a decrease in protein thiol groups and reduced glutathione levels. The liver enzymatic
antioxidant defense was modulated to maintain the redox status in response to the changes initiated by Si/SiO2 QDs.
So, catalase and glutathione peroxidase activities were upregulated starting from the first day after injection, while the
activity of superoxide dismutase increased only after 7 days. The oxidative damage that still occurred may impair the
activity of more sensitive enzymes. A significant inhibition in glucose-6-phosphate dehydrogenase and glutathione-S
-transferase activity was noted, while glutathione reductase remained unaltered.
Taking into account that the reduced glutathione level had a deep decline and the level of lipid peroxidation products
remained highly increased in the time interval we studied, it appears that the liver antioxidant defense of Carassius
gibelio does not counteract the oxidative stress induced 7 days after silicon-based QDs exposure in an efficient manner.
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The extensive research of nanoparticles in connection to
their various biological and medical applications has been
the preamble for the development of quantum dots (QDs).
These represent a heterogenous class of nanoparticles com-
posed of a semiconductor core including group II-VI or
group III-V elements encased within a shell comprised of a
second semiconductor material [1]. Due to their unique* Correspondence: diana_dinu2006@yahoo.com
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in any medium, provided the original work is poptical and chemical properties, i.e., their broad absorption
spectra, narrow fluorescence emission, intense fluorescence,
and photo bleaching resistance [2,3], QDs were proposed
as nanoprobes which were able to replace the conventional
organic dyes and fluorescent proteins [4]. The use of differ-
ent core material combinations and appropriate nanocrystal
sizes has rendered QDs useful in biosensing [5], energy
transfer [6], in vivo imaging [7], drug delivery [8], and diag-
nostic and cancer therapy applications [9].
Despite their special properties, most types of QDs have
limited use in biology and medicine due to their toxicityn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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ferent types of QDs were presented in a recent review
[11], which detailed that QD toxicity depends on a num-
ber of factors including the experimental model, concen-
tration, exposure duration, and mode of administration.
Interestingly, efforts to reduce QD toxicity include the
encapsulation in a SiO2 shell [7,12], with silicon-based
QDs being expected to be less toxic than heavy metal-
containing ones. Due to previously known benefits of
silicon, like reduced elemental toxicity, its potential
biodegradability to silicic acid and its abundance and
low costs are adding to the promising results of recent
investigations that indicate silicon use in in vivo imaging
to be a good alternative to cadmium QDs [13,14]. Nano-
porous and microparticulate forms of silicon have shown
great promise in terms of compatibility and cytotoxicity
[15]. Nonetheless, studies concerned with the biological
and medical applications of silicon-based QDs are less
numerous and still at preliminary stages [16-18].
A step towards overcoming the toxicity issue is to elu-
cidate the in vivo distribution and biological effects of
QDs that due to their variable characteristics must be
addressed individually. It is now accepted that nude
nanoparticles, including QDs, become entrapped in the
cells of the reticuloendothelial system and are preferen-
tially transported and accumulated into the liver, spleen,
and also in the kidney [4,19-24]. Once localized at this
levels, nanoparticles interact with the surrounding tissue
and cells [25].
In vitro and in vivo studies suggest that intracellular
reactive oxygen species (ROS) production is a possible
mechanism for silicon-based QDs toxicity [16,26-28].
ROS are formed continuously in all living aerobic cells
as a consequence of both oxidative biochemical reac-
tions and external factors, with them being involved in
the regulation of many physiological processes [29]. When
the production of ROS exceeds the ability of the anti-
oxidant system to balance them, oxidative stress occurs
[30]. Because ROS are highly reactive, most cellular com-
ponents are prone to oxidative damage. Consequently,
lipid peroxidation, protein oxidation, reduced glutathione
(GSH) depletion, and DNA single strand breaks could be
initiated by ROS excess. Taken together, all these changes
can ultimately lead to cellular and tissue injury and dys-
function [31].
Aquatic organisms are known for their sensitivity to
oxidative stress [32]. Fish possess systems for generating
as well as for protection against the adverse effects of
free radicals [32,33]. Due to their dependence on oxygen
availability in their environment, fish metabolism has
adapted to diminish oxygen requirements. More inter-
estingly, carp and gibel carp are capable to tolerate an-
oxia for periods that extend to months, depending on
temperature [34]. Similarly to other aestivating animals,these fish have developed remarkable antioxidant de-
fense mechanisms to cope with the return to normal
environmental conditions [35]. The most potent antioxi-
dant mechanisms are found particularly in the organs
with high metabolic activity such as the liver, kidney,
and brain [36]. Thus, the freshwater fish Carassius
gibelio is a suitable model system to evaluate the
changes induced by QDs and their putative oxidative
stress related effects.
In this study, we highlighted the in vivo accumulation
of silicon-based QDs and described the histological
changes that occurred in the hepatic tissue of the gibel
carp. We also focused on revealing the biochemical al-
terations that appeared. We evaluated the GSH concen-
tration and the levels of oxidative stress markers such as:
malondialdehyde (MDA), carbonyl derivates of proteins
(CP), protein sulfhydryl groups (PSH), and advanced oxi-
dation protein products (AOPP). Additionally, we con-
centrated on the activity of the antioxidant enzymes,
such as superoxide dismutase (SOD), catalase (CAT),
glutathione peroxidase (GPX), and glutathione-S-trans-
ferase (GST), as well as glutathione reductase (GR) and
glucose 6-phosphate dehydrogenase (G6PDH) due to
their key roles in antioxidant defense.
Methods
Chemicals
Nicotinamide adenine dinucleotide phosphate disodium
salt (NADP+), nicotinamide adenine dinucleotide phos-
phate reduced tetrasodium salt (NADPH), and 1,1,3,3-
tetramethoxy propane were supplied by Merck (Darmstadt,
Germany). The Detect X® Glutathione Colorimetric
Detection Kit was purchased from Arbor Assay (Michigan,
USA), and 2,4-dinitrophenylhydrazine was from Loba-
Chemie (Mumbai, India). All other reagents were pur-
chased from Sigma (St. Louis, MO, USA), which were of
analytical grade.
Nanoparticles
The nanoparticles used in our experiment have a crystal-
line silicon (Si) core covered by an amorphous silicon
dioxide (SiO2) surface. The Si/SiO2 nanoparticles were
prepared by pulsed laser ablation technique [37]. The
particles are spherical with a crystalline Si core covered
with a 1- to 1.5-nm thick amorphous SiO2 layer. The
diameter of the QDs was estimated by transmission elec-
tron microscopy image analysis. The size distribution is
a lognormal function, with diameters in the range be-
tween 2 and 10 nm, with the arithmetic mean value of
about 5 nm. The photoluminescent emission measured
at room temperature reached maximum intensity at ap-
proximately 690 nm (approximately 1.8 eV) [38]. A sus-
pension of nanoparticles (2 mg/mL) prepared in 0.7%
NaCl was used in the current experiment.
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The freshwater carp C. gibelio with a standard length of
13 ± 2 cm, weighing 90 ± 10 g were acquired from the
Nucet Fishery Research Station, Romania. The fish were
allowed to adjust to laboratory conditions for 3 weeks
prior to the experiment. The fish were reared in
dechlorinated tap water at a temperature of 19 ± 2°C
and pH 7.4 ± 0.05, dissolved oxygen 6 ± 0.2 mg/L (con-
stant aeration), and CaCO3 175 mg/L, with a 12-h
photoperiod. Fish were fed pellet food at a rate of 1% of
the body weight per day. Animal maintenance and ex-
perimental procedures were in accordance with the
Guide for the Use and Care of Laboratory Animals [39],
and efforts were made to minimize animal suffering and
to reduce the number of specimens used.
After the acclimatization period, the fish were randomly
divided in groups of 18. Group I represented the control
and consisted of fish intraperitoneally (IP) injected with
0.7% NaCl. Group II was the experimental group, and the
fish were IP injected with a dose of 2 mg/kg QDs (pre-
pared in 0.7% NaCl) per body weight. No food was sup-
plied to the fish during the experimental period, and no
obvious changes in fish body weight were recorded. After
1, 3, and 7 days from QDs injection, six fish from each
group were sacrificed by trans-spinal dissection and the
liver was quickly removed. Organs were immediately fro-
zen in liquid nitrogen and stored at −80°C until biochem-
ical analyses were performed.
Preparation of tissue homogenates and total protein
measurements
Liver was homogenized (1:10 w/v) using a Mixer Mill MM
301 homogenizer (Retsch, Haan, Germany) in ice-cold
buffer (0.1 M Tris-HCl, 5 mM ethylenediaminetetraacetic
acid (EDTA), pH 7.4), containing a few crystals of phenyl-
methylsulfonyl fluoride as protease inhibitor. The resulting
homogenate was centrifuged at 8,000×g for 30 min, at 4°C.
The supernatant was decanted, aliquoted, and stored
at −80°C until needed. Protein concentration was de-
termined using Lowry’s method with bovine serum al-
bumin as standard [40] and was expressed as mg/mL.
Oxidative stress markers
Lipid peroxidation
Lipid peroxidation was determined by measuring MDA
content according to the fluorimetric method of Del Rio
[41]. Briefly, 700 μL of 0.1 M HCl and 200 μL of a sam-
ple with a total protein concentration of 4 mg/mL were
incubated for 20 min at room temperature. Then, 900
μL of 0.025 M thiobarbituric acid was added, and the
mixture was incubated for 65 min at 37°C. Finally, 400
μL of Tris-EDTA protein extraction buffer was added.
The fluorescence of MDA was recorded using a Jasco
FP750 spectrofluorometer (Tokyo, Japan) with a 520/549(excitation/emission) filter. MDA content was calculated
based on a 1,1,3,3-tetramethoxy propane standard curve
with concentrations up to 10 μM. The results were
expressed as nanomoles of MDA per milligram of protein.
Protein sulfhydryl groups assay
The protein thiols were assayed using 4,4′-dithiodipyridine
(DTDP) according to the method of Riener [42]. A volume
of 100 μL of total protein extract was mixed with 100 μL
of 20% trichloracetic acid (TCA) and thoroughly homoge-
nized. After 10 min on ice, the samples were centrifuged
at 10,000×g for 10 min. The pellet was rendered soluble in
20 μL 1 M NaOH and mixed with 730 μL 0.4 M Tris-HCl
buffer (pH 9). Then, 20 μL of 4 mM DTDP were supple-
mented, and after 5-min incubation at room temperature
(in the dark), the absorbance at 324 nm was measured.
The concentration of PSH was quantified using a N-
acetylcysteine standard curve with concentrations up to
80 μM. The values were expressed as nanomoles per milli-
gram of protein.
Carbonyl derivates of proteins
CP were quantified using the reaction with 2,4-
dinitrophenylhydrazine (DNPH) according to the method
described by Levine [43]. The tissue extract was diluted to
500 μL to render a 0.1 mg/mL protein solution which was
mixed 1:1 with 10 mM DNPH (this latter solution was
prepared in 2 mM HCl). Sample blanks were prepared in
a similar manner, except DNPH was excluded. Proteins
were TCA-precipitated, and free DNPH was removed by
washing the resulting pellets with ethanol/ethyl acetate
(1:1 v/v). The pellets were rendered soluble in 600 μL 1 M
NaOH and incubated for 15 min at 37°C. Sample absorb-
ance was determined at 370 nm against its corresponding
blank. CP concentration was calculated using the molar
absorption coefficient of 22,000 M−1 cm−1. The results are
expressed as nanomoles per milligram of protein.
Advanced oxidation protein products assay
The concentration of AOPP was assessed according to
the method of Witko-Sarsat [44]. A sample of 200 μL
total protein extract (diluted to about 0.5 mg/mL) was
mixed with 10 μL 1.16 M potassium iodide and vortexed
for 5 min. A volume of 20 μL of glacial acetic acid was
added, and the mixture was vortexed again for 30 sec-
onds. Sample optical density was read at 340 nm in a
microplate reader. For quantification, a chloramine-T
standard curve with concentrations up to 100 μM was
used. The AOPP level was expressed as nanomoles per
milligram of protein.
Antioxidant enzymes activity
SOD activity was assessed by measuring the NADPΗ
oxidation by the superoxide radical at 340 nm [45]. This
Stanca et al. Nanoscale Research Letters 2013, 8:254 Page 4 of 11
http://www.nanoscalereslett.com/content/8/1/254reaction sequence generates superoxide from molecular
oxygen in the presence of EDTA, MnCl2, and mer-
captoethanol. Reagent blanks were run with each set of
analyzed samples, and the percent inhibition of NADPH
oxidation was calculated as sample rate/blank rate ×
100. One unit (U) of SOD activity was defined as the
amount of enzyme that inhibited NADPH oxidation by
50% compared to the maximal oxidation rate of the
reagent blank.
CAT activity was assessed following Aebi's method,
which measures the decrease in absorbance at 240 nm
due to H2O2 disappearance. One unit of CAT activity is
the amount of enzyme that catalyzed the conversion of 1
μmole H2O2 in 1 min [46].
Total GPX activity was assayed by a method using tert-
butyl hydroperoxide and reduced GSH as substrates [47].
The reduction of NADPH to NADP+ was recorded at 340
nm, and the concentration of NADPH was calculated using
a molar extinction coefficient of 6.22 × 103 M−1 cm−1. One
unit of activity was defined as the amount of enzyme that
catalyzes the conversion of 1 μmole of NADPH per minute
under standard conditions.
GST was measured by monitoring the formation of an
adduct between GSH and 1-chloro-2,4-dinitrobenzene
(CDNB) at 340 nm [48]. One unit of GST activity was de-
fined as the amount of enzyme that catalyzed the trans-
formation of one μmole of CDNB in conjugated product
per minute. The extinction coefficient 9.6 mM−1 cm−1 was
used for the calculation of CDNB concentration.
The activity of GR was determined by measuring the
decrease in OD at 340 nm due to NADPH consumption
in a reaction medium containing the enzyme's substrate
oxidized glutathione (GSSG) [49]. One unit of GR activ-
ity was calculated as the quantity of enzyme that con-
sumed 1 μmole of NADPH per minute.
G6PDH activity was measured by the rate of the
NADPH formation [50]. One unit of activity was defined
as the amount of G6PDH that produces 1 μmole of
NADPH per minute.
Reduced glutathione assay
GSH levels were determined using the Detect X® colori-
metric detection kit (Sigma-Aldrich, St. Louis, MO,
USA) following the manufacturer's instructions. Briefly,
the tissue homogenate was deproteinized with 5% sul-
fosalicylic acid and analyzed for total glutathione and
GSSG. GSH concentration was obtained by subtracting
the GSSG level from the total glutathione. The GSSG
and GSH levels were calculated and were expressed as
nanomoles per milligram of protein.
Histology
Freshly prelevated fragments of gibel carp liver were
fixed in Bouin solution or 4% paraformaldehyde in PBS,dehydrated in ethanol, cleared in toluene, and embed-
ded in paraffin. Sections (6-μm thick) were used for
hematoxylin-eosin (H&E) staining and fluorescence
microscopy.
Fluorescent image analysis of nanoparticles distribution
After deparafination and rehydration, the slides were
stained with 4,6-diamidino-2-phenylindole (DAPI) solu-
tion, mounted in PBS, and analyzed by epifluorescence
microscopy using a DAPI/FITC/Texas red triple band fil-
ter set (Carl Zeiss, Oberkochen, Germany). Under ultra-
violet excitation, silicon-based quantum dots appear red,
and nuclei appear blue with DAPI. The photomicrographs
were taken with a digital camera (AxioCam MRc 5, Carl
Zeiss) driven by an Axio-Vision 4.6 software (Carl Zeiss).
Statistical analysis
All data presented in this paper are shown as relative
values ± the relative standard deviation (RSD). The relative
values were obtained by dividing the mean values regis-
tered in the experimental fish group (n = 6) with the mean
values for the corresponding control group (n = 6). The
differences between control and experimental groups at
each time interval were analyzed by Student's t test and
validated by confidence intervals using Quattro Pro X3
software (Corel Corporation, Mountain View, CA, USA).
The results were considered significant only if the P value
was less than 0.05, and confidence intervals of control and
samples did not overlap. All biochemical assays were run
in triplicate.
Results and discussion
The applications of QDs in biological and medical area
showed the tremendous potential of these nanoparticles
in terms of developing new therapeutic approaches. As a
result of these, it has become increasingly important to
understand the biological response to their administra-
tion, considering that the main limitation in QD applica-
tions is their alleged toxicity.
Microscopy studies
Due to intrinsic photoluminescence under ultraviolet
excitation, silicon-based QDs have been detected in tis-
sue sections (Figure 1A,B,C,D). The QD characteristic
red fluorescent emission was not detected for any of the
control fish groups (Figure 1A). Fluorescence micros-
copy observations have indicated that silicon-based
QDs were present and accumulated in the hepatic tissue
at all time intervals (1, 3, and 7 days) (Figure 1B,C,D).
The most intense accumulation was detected 7 days
after IP injections, in hepatocytes around blood vessels
(Figure 1D).
A histological assessment was performed to determine
if silicon-based QDs accumulation cause liver damage.
Figure 1 QDs localization and accumulation in the liver of Carassius gibelio is highlighted by fluorescence microscopy. When excited in
UV, the DAPI-stained nuclei appear blue, while the Si/SiO2 QDs appear red due to their intrinsic fluorescence. (A) Liver tissue from control
(non-injected) animals. QDs are visible in the hepatocytes at 24 h (B), 72 h (C), and 7 days (D) after IP injection (arrows).
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(Figure 2A). Fish liver is composed of branching and
anastomosing cords of polygonal hepatocytes, with a
central, dictinctive, and hyperchromatic nucleus, with a
visible nucleolus. To be more specific, extensive vacuola-
tions are observed, a characteristic of cultured fish hepa-
tocytes, which often become swollen with glycogen or
neutral fat. In the liver of fish injected with silicon-based
QDs, we observed some hystological alterations. Al-
though functional phagocytic cells are occasionally ob-
served in the sinusoids of healthy liver tissue, after 1 day
of QDs exposure, we highlight an increased number of
macrophage cluster (Figure 2B). Aggregates of macro-
phages are involved in recycling, sequestration, and de-
toxification of endogenous and exogenous compounds
[51-53]. Several pathological states such as starvation
[53], parasite attack [54], nutritional imbalances [55],
and hemolytic anemias [53], can enhance macrophage
aggregate appearance. After 3 days, the proliferation of
fibrous connective tissue near sinusoids occurred, substi-
tuting liver parenchyma (Figure 2C). Hepatic fibrosis
appeared, probably due to the accumulation of extracel-
lular matrix components [56]. Oxidative stress induces
fibroblast [57] and hepatic stellate cell proliferation [58]
and also collagen synthesis [59]. Hepatocyte basophilia
and pronounced destruction of the liver arhitecture at 7
days after IP injection were observed (Figure 2D). Thecummulative effects produced by Si/SiO2 QDs accumu-
lation are possibly causing a certain degree of hepatic in-
sufficiency in gibel carp. Nonetheless, only a reduced
healthy hepatic parenchyma is required to maintain nor-
mal liver function [60].
Oxidative stress markers
The silicon quantum dots uptaken in the liver could
interact with NADPH oxidase in plasma membrane,
thus generating superoxide in the extracellular space
[61], which would enter the cells through an anion chan-
nel [62]. Then, this anion can be transformed into
hydrogen peroxide [63] which might cause a decrease in
the abundance of complex III core subunit 2 and conse-
quently a disturbance of the respiratory chain leading to
ROS generation [64]. Because it is highly reactive, ROS
may oxidize the most cellular compounds.
Malondialdehyde is an end product of lipid peroxida-
tion that is extensively used as an indirect marker of
oxidative stress [65]. IP injection of silicon-based QDs
induced an increase of the MDA level by 66% and 143%
in the liver tissue after 1 and 3 days, followed by a slight
decrease after 7 days (Figure 3).
The observed MDA pattern can be explained by taking
into account the various factors. Firstly, as thermo-
conformers, fish present acclimatory adaptations that in-
clude the enrichment of membrane lipid composition
Figure 2 Liver histology of Carassius gibelio. (A) Control (non-injected) animals. (B) Liver histopathology 24 h after IP injection indicates
accumulation of melanomacrophage centers (arrow). (C) Fibrosis (arrow) 72 h after IP injection. (D) Hepatolysis micro centers (arrow) at 7 days
after IP injection. H&E staining.
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ω-6 types for preserving membrane fluidity at lower tem-
peratures. A typical reaction during ROS-induced damage
is the peroxidation of unsaturated fatty acids [66]. Since
the relative oxidation reaction speed generally increases
with increasing unsaturation [65], fish phospholipid mem-
branes are more sensitive to oxidative reactions by ROS
than those of the mammals [67]. Hence, the highest level
of MDA registered 3 days after QDs exposure might
suggest strong on-going lipid peroxidation processes
propagated by lipid radicals that may also affect theFigure 3 Effects of silicon-based QDs on lipid peroxidation in
Carassius gibelio liver. Results are expressed as percent (%) from
controls ± RSD (n = 6); *P < 0.05; ***P < 0.001.proteins (Table 1). Secondly, due to its propagative na-
ture, lipid peroxidation of unsaturated fatty acids is less
dependent on the initial level of free radicals; once initi-
ated, it generates more reactive radicals that sustain the
oxidative reaction [65]. The decreased MDA level no-
ticed in the seventh day might be explained by the
action of liver antioxidant mechanisms which are able
to gradually quench the spread of lipid peroxidation that
is accomplished by the activation of GPX specific activ-
ity (Figure 4). Proteins are sensitive to direct ROS attack
and also to oxidative damage by lipid peroxidation
products [68]. Lipid radical transfer has been demon-
strated for reactive N group side chain aminoacids tryp-
tophan, arginine, histidine, and lysine. Tyrosine and
methionine degradation by oxidizing lipids has also
been demonstrated [69]. Due to their reactivity, lipid
peroxidation end products such asmalondialdehyde or
other lipid-derived aldehydes do not accumulate and
they form Schiff bases in the reaction of carbonyl
groups with the amino groups of proteins.
The effects of the silicon-based QDs exposure on pro-
tein oxidation in the liver tissue of C. gibelio are summa-
rized in Table 1. In our experiment, a sudden AOPP
increase by 83.5% is highlighted starting with the first
day postexposure. The presence of infiltrating macro-
phages in the hepatic parenchyma, also noted at this
early time point (Figure 2B), can account for the in-
creased AOPP level. AOPP are formed subsequent to




Control Exposed Control Exposed Control Exposed
1 100 ± 13 183.5 ± 17** 100 ± 3 87.2 ± 10* 100 ± 13 98.4 ± 11
3 100 ± 16 191.5 ± 21** 100 ± 9 65 ± 5** 100 ± 12 102.3 ± 10
7 100 ± 10 208.9 ± 14** 100 ± 6 51 ± 13** 100 ± 9 90.9 ± 17
Carbonyl derivates of proteins (CP), advanced oxidation protein products (AOPP), and protein thiol groups (PSH) in liver of fish after 1, 3, and 7 days of
silicon-based QDs exposure. Results are presented expressed as percent from controls ± RSD (n = 6); *P < 0.05; **P < 0.01.
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hypochlorite that selectively attacks proteins, aiming pri-
marily at the lysine, tryptophan, cysteine, and methio-
nine residues.
Current literature supports the role of protein thiol
groups as prime ROS targets. In fact, PSH can scavenge
50% to 75% of intracellular generated ROS, suffering re-
versible or irreversible oxidations during this process
[68]. Our data showed that PSH were reduced in the
liver of fish IP injected with Si/SiO2 QDs (Table 1). After
1 day, the PSH level diminished by about 13% while, for
longer periods, the decrease was amplified, i.e., it was re-
duced by 35% after 3 days and by 49% after 7 days. The
continuous decrease of PSH over the 7-day period may
imply that sufficient PSHs were available to be oxidized
and thus explain the protection from more severe
protein oxidative damage, such as carbonylation. Our
current results indicated that protein carbonylation is
not a characteristic alteration in silicon-based QD-
induced oxidative stress in the liver since protein
carbonyls maintained at a basal level (Table 1). Our pre-
vious results indicated a decrease in PSH content in the
kidney of C. gibelio [70], while in white muscle tissue,
this parameter remained unchanged after QDs adminis-
tration [71]. These differences are probably due to the
QDs in vivo distribution, since the liver is a main targetFigure 4 GPX and GST specific activities in liver of Carassius
gibelio injected with silicon-based QDs. Results are expressed as
percent from controls ± RSD (n = 6); *P ≤ 0.05; **P ≤ 0.01.of QDs accumulation and the kidney is involved in
the nanoparticles clearance, whereas white muscle ac-
cumulated QDs to a lesser extent due to its poor
vascularization.
Antioxidant defense system
The liver enzymatic antioxidant defense is modulated in
response to the redox status changes initiated by Si/SiO2
QDs. Figure 5 shows the different responses of SOD and
CAT to silicon-based QDs accumulation in the liver of
C. gibelio. These differences may be explained on the ac-
count of their functions. SOD activity increased by
40.1% after 7 days of QDs administration, whereas no
significant changes in the activity of this enzyme were
noticed in the first 3 days. SOD eliminates the free rad-
ical superoxide by converting it to hydrogen peroxide,
which, in turn, is cleared by CAT. Several pathways are
involved in the production of superoxide in normal cells
and tissues such as xanthine oxidase, the mitochondrial
electron transport system enzymes, NAD(P)H oxidase,
etc. [72]. The interaction of silicon QDs with these path-
ways after substantial tissue accumulation may account
for the increased superoxide radical input a week after
QDs exposure.
Our data show distinct changes in CAT activity, which
is elevated at every time interval studied, with the most
notable increase of 42% measured in the seventh dayFigure 5 The effect of silicon-based QDs on the SOD and CAT
activities in Carassius gibelio liver. Results are expressed as
percent from controls ± RSD (n = 6); ***P ≤ 0.001.
Figure 6 GSH concentration in the liver of Carassius gibelio
after silicon-based QDs administration. Results are expressed as
percent from controls ± RSD (n = 6); ***P ≤ 0.001.
Figure 7 GR and G6PD specific activities in liver of Carassius
gibelio injected with silicon-based QDs exposure. Results are
expressed as percent from controls ± RSD (n = 6); **P ≤ 0.01,
***P ≤ 0.001.
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duction of CAT would indicate the emergence of an in-
creasing source of hydrogen peroxide during a 7-day
period after QDs IP injection. It is well established that
H2O2 is produced through two-electron reduction of O2
by cytochrome P-450, D-amino acid oxidase, acetyl coen-
zyme A oxidase, or uric acid oxidase [73]. Additionally,
Kupffer cells, which are fixed to the endothelial cells lining
the hepatic sinusoids have a great capacity to endocytose
exogenous particles (including QDs) and secrete large
amounts of ROS [74]. Since the amount of QDs in the
liver accumulates gradually and is at a maximum after 7
days, we suggest that the substrate for CAT must be gen-
erated by the QDs directly or indirectly. It is possible that
the early activation of CAT may be due to an increased
production of H2O2 by a mechanism different from ·O2
−
dismutation. Indeed, the fact that H2O2 generation may be
central to silica nanoparticle toxicity has recently been de-
duced, since catalase treatment decreases the nanotoxic
effects of SiO2 nanoparticles [75].
The activity of GPX increased after 1 day of exposure
by 38% and remained approximately at this level in the
next days (Figure 4). GPX works in concert with CAT to
scavenge the endogenous hydrogen peroxide, but GPX
has much higher affinity for H2O2 than CAT suggesting
that this enzyme acts in vivo at low H2O2 concentrations
whereas CAT is activated at high substrate concentra-
tions [76]. The early activation of liver GPX and the per-
sistence of almost the same level of activity throughout
the experiment may be due to other functions of the
enzyme, like lipid radical detoxification.
The GSTs are a group of multifunctional proteins,
which play a central role in detoxification of hydroper-
oxides, by conjugation with GSH [35]. An accentuated
decrease in the levels of GST activity was observed post-
QDs treatment (Figure 4). At low GSH concentrations,
cytosolic GST is inhibited by the binding of alpha, beta-
unsaturated carbonyl derivatives to specific cysteine resi-
dues of the enzyme [77]. Such unsaturated carbonyl
derivates are formed by non-enzymatic Hock cleavage of
susceptible phospholipid molecules that contain PUFA
acyl chains [78].
A central role in managing the cellular redox status is
held by GSH. This tripeptide has a dual role serving
both as a free radical scavenger by itself as well as a sub-
strate for GPX and GST. The GSH concentration de-
creased by 60%, 78%, and 83% after 1, 3, and 7 days of
QDs treatment, compared to the corresponding controls
(Figure 6). This depletion cannot be explained by the
adaptative upregulation of GPX activity only. Also, we
have to take into consideration the contribution of GSH
conjugation with prooxidants and the hindrance of GSH
reservoir replenishment due to the GR unchanged activ-
ity (Figure 7). A decrease of intracellular GSH level wasalso reported in RAW 267.7 cells treated with silica
nanoparticles [27]. Hepatic GSH depletion by 20% has
been shown to impair the cell's defense against ROS and
is known to cause liver injury [79].
G6PDH catalyzes the first reaction of pentose phos-
phate pathway and generates NADPH involved in reduc-
tive biosynthesis and antioxidant defense. It has been
demonstrated that G6PDH ablation has deleterious
metabolic consequences, including the impairment of
hydrogen peroxide detoxification [80]. After 1 day of
exposure, the activity of G6PDH decreased by about
50% and remained reduced throughout the experiment
(Figure 7). Being a rate-limiting enzyme in the NADPH
synthesis pathway, a decrease in the NADPH/NADP+ ra-
tio probably occurred. The reduced activity of G6PDH
can be explained by the decrease of protein thiols, which
may consequently impair many enzymes [81]. Indeed,
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shown to be essential for G6PDH activity [82].
The liver GR is essential for the recycling of GSSG to
GSH, and it requires NADPH as co-substrate. NADPH
depletion may impede the upregulation of GR in order
to counteract GSH oxidation. This observation is sup-
ported by other studies that showed no significant alter-
ation in the level of GR in human epithelial cells in the
presence of pure silica nanoparticles [17].
The results reported in the literature concerning QDs
toxicity appear very divergent, and careful consideration
must be given to the differences in chemical compos-
ition, size, and dosage as well as the experimental model
chosen in the respective studies. Our data are in agree-
ment with the previous reports which reported the ROS
formation as a primary mechanism for toxicity of silicon
nanoparticles [16,26-28,75]. However, the data available
in regard to oxidative stress marker and antioxidant sys-
tems exposed to silicon QDs are limited. The results of
this study provide new but strong evidences of the direct
effects on proteins and lipids as targets of oxidative
stress induced by silicon-based QDs. The induction of
some antioxidants enzyme could explain the lesser tox-
icity of these QDs. The information on cellular state of-
fered by this study may be essential to nanoparticle
areas, helping to understand the extent to which silicon
QDs perturb the biological system.Conclusions
The results reported here make a valuable contribution
to the further understanding of the in vivo toxicity of Si/
SiO2 QDs on short and medium term, especially by out-
lining the mechanisms involved in generating their dele-
terious effects. Oxidative stress induced in fish liver by
silicon-based QDs following their accumulation is high-
lighted by the formation of MDA and AOPP and the de-
crease of PSH and GSH. The modulation of the major
antioxidant enzymes suggests a response mounted to-
wards maintaining the redox status, since both GPX and
CAT (with a later activation of SOD) are upregulated.
The oxidative damage that still occurred impaired the
activity of more sensitive enzymes, like GST, GR, and
G6PGH, which in turn further contributed to hinder the
recovery. These biochemical alterations became more in-
tense as QDs liver accumulation gradually increased.
The most extensive histological alterations, including
fibrosis and the formation of microfoci of hepatolysis
were also observed after significant QD accumulation, at
3 and 7 days, respectively, from their IP injection. A lon-
ger period of time from Si/SiO2 exposure may be needed
in order to overcome their harmful effects. We also be-
lieve that lower doses of Si/SiO2 QDs should be rela-
tively biocompatible, and careful adjustment of QDdosage may open the way for their successful use in vari-
ous in vivo imaging applications.
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